BE857219R - NEW PHARMACEUTICALLY ACTIVE COMPOUNDS - Google Patents

NEW PHARMACEUTICALLY ACTIVE COMPOUNDS

Info

Publication number
BE857219R
BE857219R BE179688A BE179688A BE857219R BE 857219 R BE857219 R BE 857219R BE 179688 A BE179688 A BE 179688A BE 179688 A BE179688 A BE 179688A BE 857219 R BE857219 R BE 857219R
Authority
BE
Belgium
Prior art keywords
active compounds
pharmaceutically active
new pharmaceutically
new
compounds
Prior art date
Application number
BE179688A
Other languages
French (fr)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of BE857219R publication Critical patent/BE857219R/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
BE179688A 1976-07-28 1977-07-27 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS BE857219R (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139376 1976-07-28

Publications (1)

Publication Number Publication Date
BE857219R true BE857219R (en) 1978-01-27

Family

ID=10322438

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179688A BE857219R (en) 1976-07-28 1977-07-27 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS

Country Status (14)

Country Link
JP (1) JPS5315371A (en)
AU (1) AU2734777A (en)
BE (1) BE857219R (en)
DE (1) DE2733952A1 (en)
DK (1) DK331977A (en)
ES (1) ES461101A2 (en)
FI (1) FI772294A (en)
FR (1) FR2359841A1 (en)
IL (1) IL52545A0 (en)
LU (1) LU77865A1 (en)
NL (1) NL7708379A (en)
NO (1) NO772669L (en)
PL (1) PL199909A1 (en)
ZA (1) ZA774221B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264614A (en) 1978-11-16 1981-04-28 Glaxo Group Limited Amine derivatives
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US5352831A (en) * 1987-09-02 1994-10-04 Ciba-Geigy Corporation Oligomeric cyanoguanidines
DE3866829D1 (en) * 1987-09-02 1992-01-23 Ciba Geigy Ag OLIGOMERS CYANOGUANIDINE.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR735087A (en) * 1930-09-01 1932-11-03 Anticoman Ges M B H Process for making polymethylene-biguanidine salts which dissolve easily in water and in gastric juice
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
US4264614A (en) 1978-11-16 1981-04-28 Glaxo Group Limited Amine derivatives
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Also Published As

Publication number Publication date
DK331977A (en) 1978-01-29
FI772294A (en) 1978-01-29
NL7708379A (en) 1978-01-31
ES461101A2 (en) 1978-12-01
LU77865A1 (en) 1977-10-24
DE2733952A1 (en) 1978-02-02
IL52545A0 (en) 1977-10-31
ZA774221B (en) 1978-06-28
PL199909A1 (en) 1978-11-20
NO772669L (en) 1978-01-31
FR2359841A1 (en) 1978-02-24
JPS5315371A (en) 1978-02-13
AU2734777A (en) 1979-02-01

Similar Documents

Publication Publication Date Title
ZA776129B (en) Pharmaceutically active compounds
BE854458A (en) ANTIHYPERTENSIFY COMPOUNDS
BE852223A (en) NEW AMINOALCOYLHETEROCYCLES
SE437827B (en) HERBICIDICALLY ACTIVE ASSOCIATIONS
DK206576A (en) PHARMACOLOGICAL ACTIVE COMPOUNDS
MA18631A1 (en) NEW HETEROCYCLIC NITROGEN COMPOUNDS
FR2346346A1 (en) NEW AMINO-CHROMANOLS
SE7710762L (en) PHARMACOLOGICALLY ACTIVE ASSOCIATIONS
BE824923A (en) NEW PHARMACEUTICALLY ACTIVE COMPOUNDS
BE850941A (en) NEW POLYPEPTIDIC COMPOUNDS
SE7702771L (en) PHARMACOLOGICALLY ACTIVE ASSOCIATIONS
FR2308364A1 (en) NEW PIPERIDINO COMPOUNDS
DK408577A (en) administration sets
FI773568A (en) PHARMACEUTICAL PREPARATION MED LAONGTIDSVERKAN
MC1156A1 (en) CYCLIC COMPOUNDS
BE857219R (en) NEW PHARMACEUTICALLY ACTIVE COMPOUNDS
BE857220R (en) NEW PHARMACEUTICALLY ACTIVE COMPOUNDS
BE850843A (en) INDOLINOSPIROPYRANE COMPOUNDS
NO771884L (en) PROCEDURES FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE POLYRIBONUCLEOTIDS
FI773812A (en) PHARMACEUTICAL FORM
BE857218A (en) NEW PHARMACEUTICALLY ACTIVE COMPOUNDS
BE837950A (en) NEW PSYCHOTROPIC POLYCLIC COMPOUNDS
BE861351A (en) ALKANOYLANILIDE COMPOUNDS AND THEIR PREPARATION
BE872492A (en) NEW DIAZOIC COMPOUNDS
FI773813A (en) PHARMACEUTICAL FORM